Abstract:The amount of scientific data and level of public sharing produced as a consequence of the COVID-19 pandemic, as well as the speed at which these data were produced, far exceeds any previous effort against a specific disease condition. This unprecedented situation allows for development and application of new research approaches. One of the major technical hurdles in immunology is the characterization of HLA-antigen-T cell receptor (TCR) specificities. Most approaches aim to identify reactive T cells starting from known antigens using functional assays. However, the need for a reverse approach identifying the antigen specificity of orphan TCRs is increasing. Utilizing large public single-cell gene expression and TCR datasets, we identified highly public CD4 + T cell responses to SARS-CoV-2, covering >75% of the analysed population. We performed an integrative meta-analysis to deeply characterize these clonotypes by TCR sequence, gene expression, HLA-restriction, and antigen-specificity, identifying strong and public CD4 + immunodominant responses with confirmed specificity. CD4 + COVID-enriched clonotypes show T follicular helper functional features, while clonotypes depleted in SARS-CoV-2 individuals preferentially had a central memory phenotype. In total we identify more than 1200 highly public CD4+ T cell clonotypes reactive to SARS-CoV-2. TCR similarity analysis showed six prominent TCR clusters, for which we predicted both HLA-restriction and cognate SARS-CoV-2 immunodominant epitopes. To validate our predictions we used an independent cohort of TCR repertoires before and after vaccination with ChAdOx1 , a replication-deficient simian adenovirus-vectored vaccine, encoding the SARS-CoV-2 spike protein. We find statistically significant enrichment of the predicted spike-reactive TCRs after vaccination with ChAdOx1 , while the frequency of TCRs specific to other SARS-CoV-2 proteins remains stable. Thus, the CD4-associated TCR repertoire differentiates vaccination from natural infection. In conclusion, our study presents a novel reverse epitope discovery approach that can be used to infer HLA- and antigen-specificity of orphan TCRs in any context, such as viral infections, antitumor immune responses, or autoimmune disease. Highlights: Identification of highly public CD4+ T cell responses to SARS-CoV-2Systematic prediction of exact immunogenic HLA class II epitopes for CD4+ T cell responseMethodological framework for reverse epitope discovery, which can be applied to other disease contexts and may provide essential insights for future studies and clinical applications.

TCR transgenic clone selection guided by immune receptor analysis and single cell RNA expression of polyclonal responders

Rapid Cloning, Expression, and Functional Characterization of Paired Αβ and Γδ T-cell Receptor Chains from Single-Cell Analysis

Rapid Cloning, Expression, And Functional Characterization Of Paired Alpha Beta And Gamma Delta T-Cell Receptor Chains From Single-Cell Analysis

Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

Single-cell RNA sequencing reveals<i>in vivo</i>signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

CoV2-TCR: a web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes

copepodTCR: Identification of Antigen-Specific T Cell Receptors with combinatorial peptide pooling

Rapid parallel reconstruction and specificity screening of hundreds of T cell receptors

T-Cell-Based Platform for Functional Screening of T-Cell Receptors Identified in Single-Cell RNA Sequencing Data Sets of Tumor-Infiltrating T-Cells

Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs

Identification of SARS-CoV-2-specific T cell and its receptor

Defining T cell receptor repertoires using nanovial-based binding and functional screening

Abstract 16: CD4+ and CD8+ TCRαβ-deficient bioluminescent reporter T cells for screening and characterization of neoantigen-specific TCRs

Defining T cell receptor repertoires using nanovial-based affinity and functional screening

Genetic determinants of distinct CD8 α/β-TCR repertoires in the genus

Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis

TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs

Investigating TCR-pMHC interactions for TCRs without identified epitopes by constructing a computational pipeline

Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery

Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers